Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manraj Singh Sra"'
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEIncorporating adjuvant cyclin-dependent kinase (CDK) 4/6 inhibitors abemaciclib and ribociclib along with endocrine therapy has been shown to improve invasive disease-free survival (iDFS) for hormone receptor–positive (HR+) human epidermal r
Externí odkaz:
https://doaj.org/article/2eed21c2148b4669a477df8386b94be7
Autor:
Manraj Singh Sra, Mehak Arora, Archisman Mazumder, Ritik Mahaveer Goyal, Giridara G Parameswaran, Jitendra Kumar Meena
IntroductionDue to the accelerated pace and quantum of scientific publication during the COVID-19 pandemic, a large number of articles on COVID-19 have been retracted. Pre-prints though not peer-reviewed offer the advantage of rapid dissemination of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7831d283c0b428d07596f6cd611eebcf
https://doi.org/10.21203/rs.3.rs-1850641/v1
https://doi.org/10.21203/rs.3.rs-1850641/v1
Autor:
Manraj Singh Sra, Shuvadeep Ganguly, Archana Sasi, Priya Sharma, Rupak Kumar Giri, Azgar Abdul Rasheed, Sameer Bakhshi
Publikováno v:
Pediatric bloodcancerREFERENCES. 69(10)
Aprepitant has been shown to reduce chemotherapy-induced nausea and vomiting in children receiving highly emetogenic chemotherapy (HEC). In this study, we assessed the cost-effectiveness of aprepitant for children receiving HEC in India, United Kingd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5192ce5d5ef05fa12a0345a848ebd35a
https://pubmed.ncbi.nlm.nih.gov/35652531
https://pubmed.ncbi.nlm.nih.gov/35652531
Autor:
Manraj Singh Sra
Publikováno v:
The National Medical Journal of India. 34:249-249
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d75364a78743cbb9f600c3d20f5da51
https://doi.org/10.25259/nmji_441_20
https://doi.org/10.25259/nmji_441_20